Connect public, paid and private patent data with Google Patents Public Datasets

Verabreichungssyteme für proteinarzneistoffe unter verwendung von membranmimetika

Info

Publication number
DE69935602D1
DE69935602D1 DE1999635602 DE69935602A DE69935602D1 DE 69935602 D1 DE69935602 D1 DE 69935602D1 DE 1999635602 DE1999635602 DE 1999635602 DE 69935602 A DE69935602 A DE 69935602A DE 69935602 D1 DE69935602 D1 DE 69935602D1
Authority
DE
Grant status
Grant
Patent type
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE1999635602
Other languages
English (en)
Other versions
DE69935602T2 (de )
Inventor
Pankaj Modi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Generex Pharmaceuticals Inc
Original Assignee
Generex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
DE1999635602 1998-09-27 1999-09-23 Verabreichungssyteme für proteinarzneistoffe unter verwendung von membranmimetika Active DE69935602D1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US09161447 US6193997B1 (en) 1998-09-27 1998-09-27 Proteinic drug delivery system using membrane mimetics
PCT/CA1999/000879 WO2000018371A1 (en) 1998-09-27 1999-09-23 Proteinic drug delivery system using membrane mimetics

Publications (1)

Publication Number Publication Date
DE69935602D1 true DE69935602D1 (de) 2007-05-03

Family

ID=22581206

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1999635602 Active DE69935602D1 (de) 1998-09-27 1999-09-23 Verabreichungssyteme für proteinarzneistoffe unter verwendung von membranmimetika
DE1999635602 Active DE69935602T2 (de) 1998-09-27 1999-09-23 Verabreichungssyteme für proteinarzneistoffe unter verwendung von membranmimetika

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE1999635602 Active DE69935602T2 (de) 1998-09-27 1999-09-23 Verabreichungssyteme für proteinarzneistoffe unter verwendung von membranmimetika

Country Status (8)

Country Link
US (1) US6193997B1 (de)
JP (1) JP2002525309A (de)
CA (1) CA2345075A1 (de)
DE (2) DE69935602D1 (de)
DK (1) DK1115381T3 (de)
EP (1) EP1115381B1 (de)
ES (1) ES2285860T3 (de)
WO (1) WO2000018371A1 (de)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US6290987B1 (en) * 1998-09-27 2001-09-18 Generex Pharmaceuticals, Inc. Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids
US6849263B2 (en) * 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
US6375975B1 (en) * 1998-12-21 2002-04-23 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary application
US6451286B1 (en) * 1998-12-21 2002-09-17 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds
US7087215B2 (en) * 1998-12-21 2006-08-08 Generex Pharmaceuticals Incorporated Methods of administering and enhancing absorption of pharmaceutical agents
US6350432B1 (en) * 1999-03-19 2002-02-26 Generex Pharmaceuticals Incorporated Pressurized container having an aerosolized pharmaceutical composition
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
US6432383B1 (en) * 2000-03-30 2002-08-13 Generex Pharmaceuticals Incorporated Method for administering insulin
EP1274719A4 (de) * 2000-04-12 2004-05-19 Human Genome Sciences Inc Albumin-fusionsproteine
US7371721B2 (en) 2000-09-18 2008-05-13 Sanos Bioscience A/S Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes
EP1326630B1 (de) 2000-09-18 2008-05-28 Sanos Bioscience A/S Verwendung von glp-2-peptiden
US7875295B2 (en) * 2001-05-09 2011-01-25 Nanomaterials Technology Pte Ltd Process for the controlled production of organic particles
EP1392243A2 (de) * 2001-05-10 2004-03-03 Kuhs GmbH & Co. KG Topische lamellare-doppelmembranstruktur-zusammensetzung, enthaltend n-acyl-ethanolamin und/oder ein quaternäre ammonium salz und/oder adenosylmethionin
US20030143191A1 (en) * 2001-05-25 2003-07-31 Adam Bell Chemokine beta-1 fusion proteins
CN1335182A (zh) * 2001-08-08 2002-02-13 华中科技大学 胰岛素口腔喷剂及其制备工艺
DE10148065A1 (de) * 2001-09-28 2003-04-17 Max Planck Gesellschaft (Ester)-Lysolecithine in Liposomen
WO2003047493A3 (en) * 2001-12-03 2003-10-16 Panos P Constantinides Stabilized reverse micelle compositions and uses thereof
EP2261250B1 (de) * 2001-12-21 2015-07-01 Human Genome Sciences, Inc. GCSF-Albumin Fusionsproteine
EP1463752A4 (de) * 2001-12-21 2005-07-13 Human Genome Sciences Inc Albuminfusionsproteine
GB0207653D0 (en) 2002-04-03 2002-05-15 Lamellar Therapeutics Ltd Methods of using lamellar bodies for therapeutic purposes
DE10214983A1 (de) * 2002-04-04 2004-04-08 TransMIT Gesellschaft für Technologietransfer mbH Vernebelbare Liposomen und ihre Verwendung zur pulmonalen Applikation von Wirkstoffen
US20040018237A1 (en) * 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
US8435942B2 (en) * 2002-05-31 2013-05-07 Transdermal Biotechnology, Inc. Methods for formulating stabilized insulin compositions
JP2005533076A (ja) * 2002-06-20 2005-11-04 ノバルテイス・コンシユーマー・ヘルス・エス・アー ムコ多糖及びプロピレングリコールを含む鼻用組成物
GB0322448D0 (en) * 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules
EP1695696A1 (de) * 2003-12-01 2006-08-30 Mitsubishi Pharma Corporation Liposom
CN1557479A (zh) * 2004-01-16 2004-12-29 深圳市海王英特龙生物技术股份有限公 干扰素脂质体乳膏
CN100548271C (zh) 2004-01-20 2009-10-14 阿勒根公司 用于眼部的局部治疗、并优选包括有曲安奈德及透明质酸的组合物
US20050238632A1 (en) * 2004-04-23 2005-10-27 Alburty David S Propellant formulations
JP2009510168A (ja) * 2005-10-03 2009-03-12 マーク エー. ピンスカイ 改善されたスキンケアのための組成物および方法
WO2010027479A3 (en) 2008-09-08 2010-10-07 Children's Medical Center Corporation Mucosal delivery of therapeutic molecules, proteins, or particles coupled to ceramide lipids
JP5892940B2 (ja) 2009-11-25 2016-03-23 アリスジェン ソシエテ アノニム クラウン化合物及び/又は対イオンと複合体化されたペプチドを含む粘膜送達組成物
US8668937B2 (en) 2011-03-17 2014-03-11 Transdermal Biotechnology, Inc. Topical nitric oxide systems and methods of use thereof
CN104105731A (zh) 2011-12-20 2014-10-15 医用粘合剂革新有限责任公司 用于生物可降解组织粘合剂的异氰酸酯官能的预聚物
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US20160151283A1 (en) * 2014-11-27 2016-06-02 Icnoderm S.R.L. Hyalurosomes, their use in topical cosmetic or pharmaceutical compositions and their preparation process

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408387B2 (de) 1975-06-30 1983-09-09 Oreal
FR2571963B1 (fr) 1984-10-24 1987-07-10 Oreal Composition a usage cosmetique ou pharmaceutique contenant des niosomes et au moins un polyamide hydrosoluble et procede de preparation de cette composition.
US5147723A (en) 1987-07-28 1992-09-15 Micro-Pak, Inc. Paucilamellar lipid vesicles
US5234767A (en) 1987-03-13 1993-08-10 Micro-Pak, Inc. Hybrid paucilamellar lipid vesicles
US4895452A (en) * 1988-03-03 1990-01-23 Micro-Pak, Inc. Method and apparatus for producing lipid vesicles
CA2067754C (en) * 1990-08-24 2002-06-04 Gregor Cevc Preparation for the application of agents in mini-droplets
US5260065A (en) 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
US5643600A (en) 1991-09-17 1997-07-01 Micro-Pak, Inc. Lipid vesicles containing avocado oil unsaponifiables
US5653987A (en) * 1995-05-16 1997-08-05 Modi; Pankaj Liquid formulations for proteinic pharmaceuticals
EP0963196B1 (de) * 1996-09-27 2005-01-19 Jagotec Ag Arzneistoffverabreichungssystem mit hyaluronsäure
US6017545A (en) * 1998-02-10 2000-01-25 Modi; Pankaj Mixed micellar delivery system and method of preparation

Also Published As

Publication number Publication date Type
US6193997B1 (en) 2001-02-27 grant
CA2345075A1 (en) 2000-04-06 application
DK1115381T3 (da) 2007-07-23 grant
ES2285860T3 (es) 2007-11-16 grant
EP1115381A1 (de) 2001-07-18 application
DE69935602T2 (de) 2007-12-06 grant
WO2000018371A1 (en) 2000-04-06 application
EP1115381B1 (de) 2007-03-21 grant
JP2002525309A (ja) 2002-08-13 application

Similar Documents

Publication Publication Date Title
DE29720299U1 (de) Teststreifen zur Blutzuckerbestimmung
DE29722473U1 (de) Trenneinrichtung zur Trennung von Substanzen
DE29707043U1 (de) Photobioreaktor
DE29712331U1 (de) Implantat zur Befestigung von Wirbeln
DE29719466U1 (de) Containerbrückensystem
DE69804857T2 (de) Integritätsprüfung von elektroden
DE29700578U1 (de) Pflaster zur transdermalen Applikation von Wirkstoffen
DE29509604U1 (de) Einrichtung zur Versorgung von Passanten mit Hörbotschaften
DE29721029U1 (de) Seitenhalter
DE29705471U1 (de) Halteelement zur Halterung von Fußleisten
DE29723901U1 (de) Einrichtung zur Belüftung von Flüssigkeiten
DE29511084U1 (de) Koffer zur Aufnahme von Medikamenten
DE29504111U1 (de) Marknagel zur Hüftkompression
DE29907351U1 (de) Einrichtung zum Zusammensetzen von Bauelementen
DE29722727U1 (de) Gelenkbeschlag für Fußteile von Lattenrosten
DE29808278U1 (de) Begrenzungselement für den Fahrbahnrand von Rennstrecken
DE29813724U1 (de) Laufrad zur unterhaltenden Betätigung von Kleintieren
DE29708994U1 (de) Teflonspender
DE29717277U1 (de) Einrichtung zur Reinigung von Walzen
DE69800262T2 (de) Bodenelement für Standflächen von Vieh
DE29707873U1 (de) Trennelement zur Unterteilung von Reling-Schubkästen
DE29601903U1 (de) Einrichtung zur Versorgung von Passanten mit Hörbotschaften
DE29714144U1 (de) Vorrichtung zur Eindämmung von Hochwasser
DE69618201T2 (de) Markieren von diamanten
DE29608976U1 (de) Vorrichtung zur seitlichen Lagerung von vorgefertigten Treppen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition